ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vermylen, P
Right arrow Articles by Sculier, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vermylen, P
Right arrow Articles by Sculier, J.
Eur Respir J 1999; 14: 806-811
Copyright © ERS Journals Ltd 1999


Original Articles

Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma

P Vermylen, C Roufosse, A Burny, A Verhest, T Bosschaerts, S Pastorekova, V Ninane, and JP Sculier

The MaTu interval (MN)/carbonic anhydrase (CA) IX tumour-associated antigen is a protein that is normally expressed in the gut and belongs to the carbonic anhydrase enzyme family (CA IX). It has been detected in tumour cell lines and in some solid tumours including cervical, oesophageal and clear cell renal carcinoma. This study determined MN/CA IX expression in 65 primary non-small cell lung cancer resected with curative intent and in 38 bronchial preneoplastic lesions, carcinoma in situ or microinvasive carcinoma as well as in normal bronchial tissue. The presence of MN/CA IX was detected using immunohistochemistry and Western blot analysis, whenever frozen material was available. Immunostaining was positive in 52/65 (80%) of the tumour samples. The staining was more often focal than diffuse. The percentage of stained cells in positive tumours was highly variable, ranging 1-85%. The pattern of immunostaining was predominantly cytoplasmic with a membranous reinforcement (87%). The intensity was mainly strong (69%). The presence of the protein in the tumour was confirmed by Western blot analysis in the eight samples tested. All the morphologically normal epithelia, except in close vicinity of tumours in some cases, as well as the preneoplastic bronchial lesions (basal cell hyperplasia, metaplasia and dysplasia) were immunonegative for MN/CA IX expression. In contrast, carcinoma in situ and microinvasive epithelioma showed the presence of MN-immunopositive tumoural cells in 5/7 and 4/5 of the samples, respectively. These data suggest that MN/CA IX is a useful marker for the differentiation between preneoplastic lesions and bronchial non-small cell lung cancer in the lung.


This article has been cited by other articles:


Home page
CarcinogenesisHome page
K. Salnikow, O. Aprelikova, S. Ivanov, S. Tackett, M. Kaczmarek, A. Karaczyn, H. Yee, K. S. Kasprzak, and J. Niederhuber
Regulation of hypoxia-inducible genes by ETS1 transcription factor
Carcinogenesis, August 1, 2008; 29(8): 1493 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. J. Brennan, K. Jirstrom, A. Kronblad, R. C. Millikan, G. Landberg, M. J. Duffy, L. Ryden, W. M. Gallagher, and S. L. O'Brien
CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance.
Clin. Cancer Res., November 1, 2006; 12(21): 6421 - 6431.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. A. Haapasalo, K. M. Nordfors, M. Hilvo, I. J. Rantala, Y. Soini, A.-K. Parkkila, S. Pastorekova, J. Pastorek, S. M. Parkkila, and H. K. Haapasalo
Expression of Carbonic Anhydrase IX in Astrocytic Tumors Predicts Poor Prognosis
Clin. Cancer Res., January 15, 2006; 12(2): 473 - 477.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
M. A. Proescholdt, C. Mayer, M. Kubitza, T. Schubert, S.-Y. Liao, E. J. Stanbridge, S. Ivanov, E. H. Oldfield, A. Brawanski, and M. J. Merrill
Expression of hypoxia-inducible carbonic anhydrases in brain tumors
Neuro-oncol, October 1, 2005; 7(4): 465 - 475.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. P. L. Bard, A. Amelink, V. N. Hegt, W. J. Graveland, H. J. C. M. Sterenborg, H. C. Hoogsteden, and J. G. J. V. Aerts
Measurement of Hypoxia-related Parameters in Bronchial Mucosa by Use of Optical Spectroscopy
Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1178 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Hilvo, M. Rafajova, S. Pastorekova, J. Pastorek, and S. Parkkila
Expression of Carbonic Anhydrase IX in Mouse Tissues
J. Histochem. Cytochem., October 1, 2004; 52(10): 1313 - 1322.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. E.B. Swinson, J. L. Jones, D. Richardson, C. Wykoff, H. Turley, J. Pastorek, N. Taub, A. L. Harris, and K. J. O'Byrne
Carbonic Anhydrase IX Expression, a Novel Surrogate Marker of Tumor Hypoxia, Is Associated With a Poor Prognosis in Non-Small-Cell Lung Cancer
J. Clin. Oncol., February 1, 2003; 21(3): 473 - 482.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. L. Olive, C. Aquino-Parsons, S. H. MacPhail, S.-Y. Liao, J. A. Raleigh, M. I. Lerman, and E. J. Stanbridge
Carbonic Anhydrase 9 as an Endogenous Marker for Hypoxic Cells in Cervical Cancer
Cancer Res., December 1, 2001; 61(24): 8924 - 8929.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Giatromanolaki, M. I. Koukourakis, E. Sivridis, J. Pastorek, C. C. Wykoff, K. C. Gatter, and A. L. Harris
Expression of Hypoxia-inducible Carbonic Anhydrase-9 Relates to Angiogenic Pathways and Independently to Poor Outcome in Non-Small Cell Lung Cancer
Cancer Res., November 1, 2001; 61(21): 7992 - 7998.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Loncaster, A. L. Harris, S. E. Davidson, J. P. Logue, R. D. Hunter, C. C. Wycoff, J. Pastorek, P. J. Ratcliffe, I. J. Stratford, and C. M. L. West
Carbonic Anhydrase (CA IX) Expression, a Potential New Intrinsic Marker of Hypoxia: Correlations with Tumor Oxygen Measurements and Prognosis in Locally Advanced Carcinoma of the Cervix
Cancer Res., September 1, 2001; 61(17): 6394 - 6399.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. K. Chia, C. C. Wykoff, P. H. Watson, C. Han, R. D. Leek, J. Pastorek, K. C. Gatter, P. Ratcliffe, and A. L. Harris
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
J. Clin. Oncol., August 15, 2001; 19(16): 3660 - 3668.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
P. Karhumaa, K. Kaunisto, S. Parkkila, A. Waheed, S. Pastorekova, J. Pastorek, W. S. Sly, and H. Rajaniemi
Expression of the transmembrane carbonic anhydrases, CA IX and CA XII, in the human male excurrent ducts
Mol. Hum. Reprod., July 1, 2001; 7(7): 611 - 616.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. J. P. Beasley, C. C. Wykoff, P. H. Watson, R. Leek, H. Turley, K. Gatter, J. Pastorek, G. J. Cox, P. Ratcliffe, and A. L. Harris
Carbonic Anhydrase IX, an Endogenous Hypoxia Marker, Expression in Head and Neck Squamous Cell Carcinoma and its Relationship to Hypoxia, Necrosis, and Microvessel Density
Cancer Res., July 1, 2001; 61(13): 5262 - 5267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Ivanov, S.-Y. Liao, A. Ivanova, A. Danilkovitch-Miagkova, N. Tarasova, G. Weirich, M. J. Merrill, M. A. Proescholdt, E. H. Oldfield, J. Lee, et al.
Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer
Am. J. Pathol., March 1, 2001; 158(3): 905 - 919.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. C. Wykoff, N. Beasley, P. H. Watson, L. Campo, S. K. Chia, R. English, J. Pastorek, W. S. Sly, P. Ratcliffe, and A. L. Harris
Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast
Am. J. Pathol., March 1, 2001; 158(3): 1011 - 1019.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. C. Wykoff, N. J. P. Beasley, P. H. Watson, K. J. Turner, J. Pastorek, A. Sibtain, G. D. Wilson, H. Turley, K. L. Talks, P. H. Maxwell, et al.
Hypoxia-inducible Expression of Tumor-associated Carbonic Anhydrases
Cancer Res., December 1, 2000; 60(24): 7075 - 7083.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.